Health Care
"There's been no indication -- absolutely no indication -- of a hung jury," Villwock says. "The jury continues to ask for certain pieces of the court transcript to be read, and it appears to be going through all of the counts very judiciously. It sounds like they are doing a good job -- which is a good thing."
Looking ahead, Tenet could find itself embroiled in a Supreme Court case next. In a press release issued Tuesday, AAPS boasted that it had assembled a "dream team" of doctors and lawyers to fight a potentially precedent-setting case against one of the company's hospitals. For his part, Dershowitz portrayed the case as an important one for the entire country. "Physicians who are entrusted with the care of their patients can see their professional careers destroyed if they dare to challenge a hospital's practices," Dershowtiz said. "When a 'whistle-blowing' physician is retaliated against, it threatens not only the physician's livelihood, but the care of all patients. This is a case, therefore, that affects every patient and potential patient in America." Critics have long accused Tenet of placing corporate profits ahead of patient care. The company has already paid a number of significant fines in the past and continues to seek a global government settlement to resolve the slew of allegations still pending. It has maintained its innocence all along. Get Jim Cramer's picks for 2006.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |


Connect with TheStreet